Dyne Therapeutics Inc (DYN)

R&D Expense Growth

50.83%

Quarterly · Period ending:

DYN logo

DYN R&D Expense Growth

Latest reported50.83%
DYN Quarterly R&D Growth (QoQ) (0.00% → 50.83%)
High-resolution chart · PNG

DYN r&d expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Dyne Therapeutics Inc R&D Expense Growth — Quarterly
Period endingR&D Expense Growth
50.8281%
5.7193%
-1.8391%
-2.0325%
-6.7743%
30.1229%
-11.8481%
49.0452%
39.7943%
-24.31%
6.503%
-6.5601%
57.5288%
13.0943%
-4.2688%
-25.7029%
65.2642%
-33.2498%
15.8614%
52.9407%
28.1718%
-15.7164%
128.3087%
31.9744%
20.4467%
42.9678%
42.8236%
56.9887%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.